Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Genmab
Bristol-Myers Squibb
Neonc Technologies, Inc.
Tesaro, Inc.
Toray Industries, Inc
Iovance Biotherapeutics, Inc.
M.D. Anderson Cancer Center
Shanghai Junshi Bioscience Co., Ltd.
Seagen Inc.